Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study

AIM: To report adalimumab (Ada) efficacy on articular-gastrointestinal disease and health-related quality of life (HRQoL) in patients with enteropathic spondyloarthritis (ES). METHODS: A cohort of 52 patients with ES was evaluated in the departments of gastroenterology and internal medicine. At base...

Descripción completa

Detalles Bibliográficos
Autores principales: Luchetti, Michele Maria, Benfaremo, Devis, Ciccia, Francesco, Bolognini, Laura, Ciferri, Monia, Farinelli, Alessia, Rossini, Matteo, Mosca, Piergiorgio, Triolo, Giovanni, Gabrielli, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656461/
https://www.ncbi.nlm.nih.gov/pubmed/29093622
http://dx.doi.org/10.3748/wjg.v23.i39.7139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656461/
https://www.ncbi.nlm.nih.gov/pubmed/29093622
http://dx.doi.org/10.3748/wjg.v23.i39.7139

Ejemplares similares